Cargando…
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors
Cognitive impairment is a multifactorial and multi-step pathological process that places a heavy burden on patients and the society. Neuroinflammation is one of the main factors leading to cognitive impairment. The inflammasomes are multi-protein complexes that respond to various microorganisms and...
Autores principales: | Xu, Yi, Yang, Yanling, Chen, Xi, Jiang, Danling, Zhang, Fei, Guo, Yao, Hu, Bin, Xu, Guohai, Peng, Shengliang, Wu, Lidong, Hu, Jialing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621314/ https://www.ncbi.nlm.nih.gov/pubmed/37915104 http://dx.doi.org/10.1186/s40035-023-00381-x |
Ejemplares similares
-
Hsp22 pretreatment protects against LPS-induced hippocampal injury by alleviating neuroinflammation and apoptosis by regulating the NLRP3/Caspase1/IL-1β signaling pathway in mice
por: Peng, Shengliang, et al.
Publicado: (2023) -
Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019) -
Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
por: Xu, Yi, et al.
Publicado: (2023) -
MicroRNA-138-5p Regulates Hippocampal Neuroinflammation and Cognitive Impairment by NLRP3/Caspase-1 Signaling Pathway in Rats
por: Feng, Xiaojin, et al.
Publicado: (2021) -
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)